Evaluation of the Temporal Window for Drug Delivery Following Ultrasound-mediated Membrane Permeability Enhancement

Overview

Journal Mol Imaging Biol

Publisher Springer

Specialties Molecular Biology
Radiology

Date 2010 Jun 4

PMID 20521134

Citations 26

Authors

Anna Yudina

Matthieu Lepetit-Coiffe

Chrit T W Moonen

Affiliations

Soon will be listed here.

Abstract

Purpose: Ultrasound-induced cavitation facilitates cellular uptake of drugs via increased membrane permeability. Here, the purpose was to evaluate the duration of enhanced membrane permeability following ultrasound treatment in cell culture.

Procedures: Optical chromophores with fluorescence intensity increasing 100-1,000-fold upon intercalation with nucleic acids served as smart agents for reporting cellular uptake. Opticell chambers with a monolayer of C6 cells were subjected to ultrasound in the presence of microbubbles followed by varying delays between 0 and 24 h before addition of Sytox Green optical contrast agent. Micro- and macroscopic fluorescence were used for qualitative and quantitative analysis.

Results: Up to 25% of viable cells showed uptake of contrast agent with a half time of 8 h, with cellular uptake persisting even at 24 h. Only cells exposed to ultrasound showed the effect.

Conclusion: The temporal window of increased membrane permeability is much longer in these studies than previously suggested. This may have important repercussions for in vivo studies in which membrane permeability may be temporally separated from drug delivery.

Citing Articles

Ultrasound Triggering of Liposomal Nanodrugs for Cancer Therapy: A Review.

Bahutair W, Abuwatfa W, Husseini G Nanomaterials (Basel). 2022; 12(17).

PMID: 36080088 PMC: 9458162. DOI: 10.3390/nano12173051.

Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.

Zhang M, Hu W, Cai C, Wu Y, Li J, Dong S Mater Today Bio. 2022; 14:100223.

PMID: 35243298 PMC: 8881671. DOI: 10.1016/j.mtbio.2022.100223.

A synergistic bactericidal effect of low-frequency and low-intensity ultrasound combined with levofloxacin-loaded PLGA nanoparticles on M. smegmatis in macrophages.

Xie S, Li G, Hou Y, Yang M, Li F, Li J J Nanobiotechnology. 2020; 18(1):107.

PMID: 32727616 PMC: 7388535. DOI: 10.1186/s12951-020-00658-7.

In vitro Ultrasonic Potentiation of 2-Phenylethynesulfonamide/Magnetic Fluid Hyperthermia Combination Treatments for Ovarian Cancer.

Merida F, Rinaldi C, Juan E, Torres-Lugo M Int J Nanomedicine. 2020; 15:419-432.

PMID: 32021188 PMC: 6982443. DOI: 10.2147/IJN.S217870.

In vitro potentiation of doxorubicin by unseeded controlled non-inertial ultrasound cavitation.

Fant C, Lafond M, Rogez B, Suarez Castellanos I, Ngo J, Mestas J Sci Rep. 2019; 9(1):15581.

PMID: 31666639 PMC: 6821732. DOI: 10.1038/s41598-019-51785-7.

References

Mehier-Humbert S, Yan F, Frinking P, Schneider M, Guy R, Bettinger T . Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjug Chem. 2007; 18(3):652-62. DOI: 10.1021/bc0602432. View

Simone E, Ding B, Muzykantov V . Targeted delivery of therapeutics to endothelium. Cell Tissue Res. 2008; 335(1):283-300. PMC: 3074598. DOI: 10.1007/s00441-008-0676-7. View

Greis C . Technology overview: SonoVue (Bracco, Milan). Eur Radiol. 2005; 14 Suppl 8:P11-5. View

Hancock H, Smith L, Cuesta J, Durrani A, Angstadt M, Palmeri M . Investigations into pulsed high-intensity focused ultrasound-enhanced delivery: preliminary evidence for a novel mechanism. Ultrasound Med Biol. 2009; 35(10):1722-36. PMC: 2752481. DOI: 10.1016/j.ultrasmedbio.2009.04.020. View

van Wamel A, Kooiman K, Harteveld M, Emmer M, Ten Cate F, Versluis M . Vibrating microbubbles poking individual cells: drug transfer into cells via sonoporation. J Control Release. 2006; 112(2):149-55. DOI: 10.1016/j.jconrel.2006.02.007. View

Hallow D, Mahajan A, Prausnitz M . Ultrasonically targeted delivery into endothelial and smooth muscle cells in ex vivo arteries. J Control Release. 2007; 118(3):285-93. PMC: 1892790. DOI: 10.1016/j.jconrel.2006.12.029. View

Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K . Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 2002; 9(6):372-80. DOI: 10.1038/sj.gt.3301678. View

ONeill B, Vo H, Angstadt M, Li K, Quinn T, Frenkel V . Pulsed high intensity focused ultrasound mediated nanoparticle delivery: mechanisms and efficacy in murine muscle. Ultrasound Med Biol. 2008; 35(3):416-24. PMC: 2668521. DOI: 10.1016/j.ultrasmedbio.2008.09.021. View

Treat L, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K . Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer. 2007; 121(4):901-7. DOI: 10.1002/ijc.22732. View

10.

Saito M, Mazda O, Takahashi K, Arai Y, Kishida T, Shin-Ya M . Sonoporation mediated transduction of pDNA/siRNA into joint synovium in vivo. J Orthop Res. 2007; 25(10):1308-16. DOI: 10.1002/jor.20392. View

11.

Deckers R, Rome C, Moonen C . The role of ultrasound and magnetic resonance in local drug delivery. J Magn Reson Imaging. 2008; 27(2):400-9. DOI: 10.1002/jmri.21272. View

12.

Lionetti V, Fittipaldi A, Agostini S, Giacca M, Recchia F, Picano E . Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. Ultrasound Med Biol. 2008; 35(1):136-43. DOI: 10.1016/j.ultrasmedbio.2008.07.011. View

13.

Meijering B, Juffermans L, van Wamel A, Henning R, Zuhorn I, Emmer M . Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res. 2009; 104(5):679-87. DOI: 10.1161/CIRCRESAHA.108.183806. View

14.

Rapoport N, Kennedy A, Shea J, Scaife C, Nam K . Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J Control Release. 2009; 138(3):268-76. PMC: 2746980. DOI: 10.1016/j.jconrel.2009.05.026. View

15.

Dittmar K, Xie J, Hunter F, Trimble C, Bur M, Frenkel V . Pulsed high-intensity focused ultrasound enhances systemic administration of naked DNA in squamous cell carcinoma model: initial experience. Radiology. 2005; 235(2):541-6. DOI: 10.1148/radiol.2352040254. View

16.

Tartis M, McCallan J, Lum A, LaBell R, Stieger S, Matsunaga T . Therapeutic effects of paclitaxel-containing ultrasound contrast agents. Ultrasound Med Biol. 2006; 32(11):1771-80. DOI: 10.1016/j.ultrasmedbio.2006.03.017. View

17.

Larkin J, Casey G, Tangney M, Cashman J, Collins C, Soden D . Effective tumor treatment using optimized ultrasound-mediated delivery of bleomycin. Ultrasound Med Biol. 2007; 34(3):406-13. DOI: 10.1016/j.ultrasmedbio.2007.09.005. View

18.

Kinoshita M, Hynynen K . A novel method for the intracellular delivery of siRNA using microbubble-enhanced focused ultrasound. Biochem Biophys Res Commun. 2005; 335(2):393-9. DOI: 10.1016/j.bbrc.2005.07.101. View

19.

Hernot S, Klibanov A . Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev. 2008; 60(10):1153-66. PMC: 2720159. DOI: 10.1016/j.addr.2008.03.005. View

20.

Yuh E, Shulman S, Mehta S, Xie J, Chen L, Frenkel V . Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model. Radiology. 2005; 234(2):431-7. DOI: 10.1148/radiol.2342030889. View